About us Pricing ContactSubscribe

I

Igor Bondarenko

Dnipro State Medical UniversityORCID https://orcid.org/0000-0002-7071-2471

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

The Lancet Oncology20141,891 citations

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

The Lancet Oncology20161,795 citations

Igor Bondarenko · Scinovex